Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. - Wikidata - awgldk - TriplyDB

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

http://www.wikidata.org/entity/Q40629471

about

Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols Current and future treatments for hepatocellular carcinoma Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation Laparoscopic vs open approach to resection of hepatocellular carcinoma in patients with known cirrhosis: systematic review and meta-analysis Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantation 2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.Laparoscopic liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: midterm results and perspectives.Thermal ablation of hepatocellular carcinoma.Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety.Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors?Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation.Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis.Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting.Resection of hepatitis B virus-related hepatocellular carcinoma: evolving strategies and emerging therapies to improve outcome Survival analysis of patients with stage I and II hepatocellular carcinoma after a liver transplantation or liver resection.Management of small hepatocellular carcinoma: a review of transplantation, resection, and ablation.The stratifying value of Hangzhou criteria in liver transplantation for hepatocellular carcinoma.Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma.Review article: liver transplantation for HCC. Treatment options on the waiting list.Early Hepatocellular Carcinoma: Transplantation versus Resection: The Case for Liver Resection.Transcatheter arterial chemoembolization of hepatocellular carcinoma as a bridge to liver transplantation: a retrospective study.Long-term outcomes of hepatic resection versus living donor liver transplantation for hepatocellular carcinoma: a propensity score-matching study.Which is more cost-effective under the MELD system: primary liver transplantation, or salvage transplantation after hepatic resection or after loco-regional therapy for hepatocellular carcinoma within Milan criteria?Impact of neo-adjuvant Sorafenib treatment on liver transplantation in HCC patients - a prospective, randomized, double-blind, phase III trial.Does microvascular invasion affect outcomes after liver transplantation for HCC? A histopathological analysis of 155 consecutive explants.Resection vs thermal ablation of small hepatocellular carcinoma: What's the first choice?Hepatic artery and biliary complications in liver transplant recipients undergoing pretransplant transarterial chemoembolization.Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation Smaller grafts do not imply early recurrence in recipients transplanted for hepatocellular carcinoma: A Chinese experience Multimodality Imaging of Ethiodized Oil-loaded Radiopaque Microspheres during Transarterial Embolization of Rabbits with VX2 Liver Tumors.Transplantation vs resection for hepatocellular carcinoma with compensated liver function after downstaging therapy Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card.Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B.Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.Prognosis for recipients with hepatocellular carcinoma of salvage liver transplantation versus those of primary liver transplantation: a retrospective single-center study.

P2860

Q26783881-773E02E7-F0AB-4354-8835-D6748CBAA3EC Q26801211-0893904F-4838-43DD-B5A8-07FF5C7D8692 Q26852105-D5CCBA5B-64BC-4F86-8662-6371E7462460 Q26864259-474F27E4-7485-443D-81E7-094EF32DE00F Q26998606-2151571F-0F3E-4019-ACA2-07A8B78759A6 Q27005375-9B67478F-7327-4790-B88A-96609B6657A7 Q28392783-433E0BE0-6FE1-4CC1-8014-A50229BD355E Q28394414-E98B5297-3824-4C5E-8071-A75BEE0F2802 Q30430659-07D85A43-CA3D-4AE3-8333-0F3E7192B0A3 Q33237223-0DAB1524-BC9E-4302-90DB-DBE5F3D2D7C8 Q33323261-9A7860C0-80A0-4D5D-8B34-EA74EBA41C45 Q33514014-60BCC23D-856F-48FF-A1EB-BFEFA3AEAEBE Q33872038-70BD4506-2098-43BF-9383-7FBFD59C0735 Q33960740-8AF4456F-7BD1-41A7-A354-90E25D6CC887 Q34067940-0954893A-A7EE-4BB2-8738-45155A27016F Q34080984-295EFDA8-A749-47BE-918F-B28AA12A3D4F Q34131801-24343B71-DB16-4ADF-A62B-4C98148471D3 Q34207805-37A80C41-4380-4C39-A71B-257B65812685 Q34618740-06662447-D80D-4B8F-BE3B-3D1FE5B0B9C8 Q35081063-D6AED30D-DEB0-406E-A03F-45B830145825 Q35133600-6C0F50A8-BA12-45B3-B79B-A68D19879361 Q35145063-D51394F7-5D86-4491-A967-90DEE40C41FA Q35145087-4ED8D55B-29B6-49D0-AA00-958B0F7B3D1B Q35207490-A85A7CED-EBDF-4735-8543-9E3535DCFD9E Q35207822-16F4A91C-1BC4-4F90-ACFC-9C503BACE78B Q35422169-362F870A-BA96-4942-AE9A-F97552FAD92A Q35613914-161D568C-4772-47A5-8F58-4813085D54B1 Q35625989-C033F822-CFE3-4174-B8B7-605D3AD9D4D7 Q35751531-1ED56122-D35E-4B97-BD31-9244481DD73D Q36681469-3C69C9F0-9EA3-4F25-B9FB-F35B3D0E7B9B Q36720150-3C0813DE-585E-4BEE-9F14-B595D5D8D3A8 Q36924891-710F9A82-32AC-431B-A2DD-1E3714979E41 Q36937325-2A656098-76B1-4756-BA6E-43AB4FC2EA86 Q36950674-3AB0BF9A-05EA-4EAA-AC61-2A686A67C43E Q37034067-91ED6B1B-C8D3-42D6-9587-78C19349DCE2 Q37045547-60045504-279A-4341-ACC6-1D0FC0181A88 Q37068256-70F6785D-CC49-48E9-9A9D-400211C9AA17 Q37212974-BA98BA2B-305C-4CE9-9EB2-846BBA4E86CF Q37247967-F2F9B84C-A29C-452B-AB39-D4EBBAA670B0 Q37348269-20B0DECE-CA47-422A-A064-F86459ACB72C

P2860

Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.

http://www.wikidata.org/entity/Q40629471

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Liver transplantation for hepa ...... dropout from the waiting list.

@en

type

label

Liver transplantation for hepa ...... dropout from the waiting list.

@en

prefLabel

Liver transplantation for hepa ...... dropout from the waiting list.

@en

P1433

Q40629471-06C67E9F-BC24-4919-BA51-B0852560A6B1

P1476

Q40629471-31836E35-C289-446C-B5BD-BFE1F2C07F56

P2093

Q40629471-0F2817D0-7C7F-4339-8A19-A88CDCA9788B

Q40629471-63ED575A-39E7-45B1-AC23-FCA173291C31

Q40629471-90FD7BF8-BD72-4900-92FF-CAAEBC5D30B0

Q40629471-9A452D41-694D-478D-AF5F-582E0211C590

Q40629471-C8DBBEFE-F7A3-4A6A-956B-A77CFDF340F7

Q40629471-D01F08FA-5358-431D-BDCD-34EA8948384C

Q40629471-EAA9D7D9-11DB-4978-97E7-166CAF7E78B4

Q40629471-F456098C-D9E0-4527-AE42-3950C4C94029

P2860

Q40629471-0331EB50-17D2-4167-A833-F4C32657C4D8

Q40629471-050809C1-63BD-42AB-8371-53929C8C9830

Q40629471-0F0745EA-30AA-4604-B238-AF84C9DB9A92

Q40629471-27D37759-457B-45D7-801C-039AC9708167

Q40629471-2B37136F-8D10-4EDC-9074-F9C0D0D4E39E

Q40629471-31E586F6-8C86-4A9E-8A92-F780B1F0E04A

Q40629471-43E71774-35E9-4308-8906-D9D88DA3D29E

Q40629471-505B7854-A554-43CA-ADC2-49E75804E287

Q40629471-576657F8-6947-4E52-9842-90CBBF69DE05

Q40629471-6A73C5B9-A70C-49E6-9D8B-5A0ECB4E2FE7

P304

Q40629471-E3CB13F3-F1B1-4053-952D-111C59491C47

P31

Q40629471-15042FBC-93D6-4E3D-A7BF-33BCC54D8537

P356

Q40629471-1E8DCC20-0243-4BD3-B81C-21F1AB7BFAEB

P433

Q40629471-68F8F22E-275A-4618-B96F-E5779AAE63E6

P478

Q40629471-75928768-0735-43CD-A1D6-C259FA785316

P577

Q40629471-2FF5B2CB-A3E8-4DEB-82BF-E36D1EEC9812

P5875

Q40629471-9C622A54-1F6F-4E70-830E-F1D4B5645DA4

P698

Q40629471-E7A35910-0D32-494B-B044-9CA697815569

P921

Q40629471-31FC1B53-24B4-4B2D-8AD9-ACAFFAA0E033

P356

JLTS.2002.34923

P1433

Liver Transplantation

P1476

Liver transplantation for hepa ...... dropout from the waiting list.

@en

P2093

Bev Nikolai

http://www.w3.org/2001/XMLSchema#string

Francis Y Yao

http://www.w3.org/2001/XMLSchema#string

John P Roberts

http://www.w3.org/2001/XMLSchema#string

Nancy L Ascher

http://www.w3.org/2001/XMLSchema#string

Nathan M Bass

http://www.w3.org/2001/XMLSchema#string

Robert Kerlan

http://www.w3.org/2001/XMLSchema#string

Timothy J Davern

http://www.w3.org/2001/XMLSchema#string

Victor Wu

http://www.w3.org/2001/XMLSchema#string

P2860

A model to predict survival in patients with end-stage liver disease

Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies.

MELD and PELD: application of survival models to liver allocation.

Transection of the oesophagus for bleeding oesophageal varices.

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

P304

873-883

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/JLTS.2002.34923

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11098064

http://www.w3.org/2001/XMLSchema#string

P698

12360427

http://www.w3.org/2001/XMLSchema#string

P921

liver transplantation